Current trends in the detection of antigenaemia, metabolites and cell wall markers for the diagnosis and therapeutic monitoring of fungal infections

Medical Mycology, Supplement

Volumn 36, Issue 1, 1998, Pages 146-155

  Verweij, P E ^a   Poulain, D ^b   Obayashi, T ^c   Patterson, T F ^d   Denning, D W ^e   Ponton, J ^f  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIV LILLE   (France)

^c JICHI MEDICAL UNIVERSITY   (Japan)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

^f UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Aspergillosis candidiasis; ELISA latex agglutination; Galactomannan; Glucan

Indexed keywords

ANTIGEN; GALACTOMANNAN; GLUCAN; MARKER;

ANTIGEN DETECTION; ASPERGILLOSIS; CANDIDIASIS; CELL WALL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; LATEX AGGLUTINATION TEST; METABOLITE; MYCOSIS; PATIENT MONITORING; REVIEW;

ANTIGENS, FUNGAL; ASPERGILLOSIS; CANDIDIASIS; CLINICAL TRIALS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCANS; HUMANS; IMMUNOLOGIC TESTS; LATEX FIXATION TESTS; MALE; MANNANS; MYCOSES;

EID: 33747102670     PISSN: 09668454     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Young R, Bennett JE. Invasive aspergillosis: absence of detectable antibody response. Am Rev Resp Dis 1971; 104: 710-16.
2. Reiss E, Lehmann PF. Galactomannan antigenemia in invasive aspergillosis. Infect Immun 1979; 25: 357-65.
3. Dupont B, Improvisi L, Provost F. Détection de galactomannane dans les aspergillosis invasives humaines et animales avec un test au latex. Bull Soc Fr Mycol Med 1990; 19: 464-70.
4. Talboi GH, Weiner MH, Gerson SL, Provencher M, Hurwitz S. Serodiagnosis of invasive aspergillosis in patients with hematologic malignancy: validation of the Aspergillus fumigatus antigen radioimmunoassay. J Infect Dis 1987; 155: 12-27.
5. Sabetta JR, Miniter P, Andriole VT. The diagnosis of invasive aspergillosis by an enzyme-linked immunosorbent assay for circulating antigen. J Infect Dis 1985; 152: 946-53.
6. Stynen D, Goris A, Sarfati J, Latgé JP. A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis. J Clin Microbiol 1995; 33: 497-500.
7. Stynen D, Sarfati J, Goris A, Prévost MC, Lesourd M, Kamphuis H, Darras V, Latgé JP. Rat monoclonal antibodies against Aspergillus galactomannan. Infect Immun 1992; 60: 2237-45.
8. Haynes K, Rogers TR. Retrospective evaluation of a latex agglutination test for diagnosis of invasive aspergillosis in immunocompromised patients. Eur J Clin Microbiol Infect Dis 1994; 13: 670-4.
9. Sulahin A, Talbot M, Ribaud P, Sarfati J, Gluckman E, Latgé JP, Deroum F. Comparison of an enzyme linked immunoassay and latex agglutination test for detection of galactomannan in the diagnosis of invasive aspergillosis. Eur J Clin Microbiol Infect Dis 1996; 15: 139-45.
10. Manso E, Montillo M, De Sio G, D'Amico S, Discepoli G, Leoni P. Value of antigen and antibody detection in the serological diagnosis of invasive aspergillosis in patients with hematological malignancies. Eur J Clim Microbiol Infect Dis 1994; 13: 756-60.
11. Ansorg R, Heintschel von Heinegg E, Rath PM. Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 1994; 13: 582-89.
12. Hopwood V, Johnson EM, Cornish JM, Foot ABM, Evans EGV, Warnock DW. Use of the Pastorex Aspergilus antigen latex agglutination test for the diagnosis of invasive aspergillosis. J Clin Pathol 1995; 48: 210-13.
13. Vogeser M, Haas A, Aust D, Ruckdeschel G. Postmortem analysis of invasive aspergillosis in a tertiary care hospital. Eur J Clin Microbiol Infect Dis 1997; 16: 1-6.
14. Verweij PE, Stynen D, Rijs AJMM, De Pauw BE, Hoogkamp-Korstanje JAA, Meis JFGM. Sandwich enzyme-linked immunosorbent assay compared with Pastorex latex agglutination test for diagnosing invasive aspergillosis in immunocompromised patients J Clin Microiol 1995; 33: 1912-4
15. Caillot D, Casasnovas O, Bernard A, Cauvaillier JF, Durand C, Cuisenier B, Solary E, Piard F, Petrella T, Bonnin A, Couillault G, Dumas M, Guy H. Improved management of invasive aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15: 139-47.
16. Grundy MA, Barnes RA, Coakley WT. Highly sensitive detection of fungal antigens by ultrasound-enhanced latex agglutination. J Med Vet Mycol 1995; 33: 201-3.
17. Verweij PE, Rijs AJMM, De Pauw BE, Horrevorts AM, Hoogkamp-Korstanje JAA, Meis JFGM. Clinical evaluation and reproducibility of the Pastorex Aspergillus antigen latex agglutination test for diagnosing invasive aspergillosis. J Clin Pathol 1995; 48: 474-6.
18. Rohrlich P, Sarfati J, Mariani P, Duval M, Carol A, Saint-Martin C, Bingen E, Latgé JP, Vilmer E. Prospective sandwich enzyme linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis. Pediatr Infect Dis J 1996; 15: 232-7.
19. Erjavec Z, Tomee Ch, Brinker M, Kauffman HF, Tabouret M, Ruiters M, Halie MR. The galactomannan ELISA test in invasive aspergillosis. 3rd Meeting of the European Confederation of Medical Mycology, Lisbon 1996; p. 3.6 (abstract).
20. Poirot JL, Isnard F, Lesage S, Leluan P, Tabouret M. Detection by ELISA of Aspergillus galactomannan in sera from hematological patients. 3rd Meeting of the European Confederation of Medical Mycology, Lisbon 1996; p. 3.21 (abstract).
21. Tabone MD, Vu Thien H, Latgé JP, Landman-Parker J, Leverger G. Value of galactomannan detection by ELISA in the diagnosis and follow-up of invasive aspergillosis. 3rd Meeting of the European Confederation of Medical Mycology, Lisbon 1996; p. 3.22 (abstract).
22. Verweij PE, Latgé JP, Rijs AJMM, Melchers WJG, De Pauw BE, Hoogkamp-Korstanje JAA, Meis JFGM. Comparison of antigen detection and PCR assay using broncho-alveolar lavage fluid for diagnosing invasive pulmonary aspergillosis in patients receiving treatment for hematological malignancies. J Clin Microbiol 1995; 33: 3150-3.
23. Verweij PE, Dompeling EC, Donnelly JP, Schattenberg AVMB, Meis JFGM. Serial monitoring of Aspergillus antigen in the early diagnosis of invasive aspergillosis. Preliminary investigations with two examples. Infection 1997; 25: 86-9.
24. Patterson TF, Miniter P, Patterson JE, Rappeport JM, Andriole VT. Aspergillus antigen detection in the diagnosis of invasive aspergillosis. J Infect Dis 1995; 171: 1553-8.
25. Swanink CMA, Meis JFGM, Rijs AJMM, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997; 35: 257-60.
26. Verweij PE, Donnelly JP, De Pauw BE, Meis JFGM. Prospects for the early diagnosis of invasive aspergillosis in the immunocompromised patient. Rev Med Microbiol 1996; 7: 105-13.
27. Taschdjian C, Seelig M, Kozin P. Serological diagnosis of Candida infections. Crit Rev Clin Lab Sci 1973; 4: 19-59.
28. Bodey G. (ed). Candidiasis, Pathogenesis, Diagnosis, and Treatment, 2nd edn. New York: Raven Press, 1993.
29. Van Deventer A, Van Vliet H, Hop W, Goessens W. Diagnostic value of anti-Candida enolase antibodies J Clin Microbiol 1994; 32: 17-23.
30. Matthews R, Burnie J, Lee W. The application of epitope mapping in the development of a new serological test for systemic candidosis. J Immunol Meth 1991; 143: 73-9.
31. Switchenko A, Miyada C, Goodman T, Walsh T, Wong B, Backer M, Ullman E. An automated enzymatic method for measurement of D-arabinitol, a metabolite of pathogenic Candida species. J Clin Microbiol 1994; 32: 92-7.
32. Walsh T, Hathom W, Sobel J, Herz W, Sanchez V, Maret M, Buckley H, Pfaller M, Schaufele R, Silva C, Navaro E, Lecciones J. Chandrasekar P, Lee J, Pizzo P. Detection of circulating Candida enolase by immunoassay in cancer patients with invasive candidiasis. N Engl J Med 1991; 15: 1026-31.
33. Obayashi T, Yoshiba M, Mori T, Goto H, Yasuoka A, Iwasaki H, Teshima H, Kohno S, Horiuchi A, Ito A, Yamaguchi H, Shimada K. Plasma (1→3) -β-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17-20.
34. Nakamura A, Ishikawa N, Suzuki H. Diagnosis of invasive candidiasis by detection of mannan antigen by using avidin-biotin enzyme immunoassay. J Clin Microbiol 1991; 29: 2363-7.
35. Chryssanthou E, Andersson B, Petrini B, Lefdahl S, Tollemar J. Detection of Candida albicans DNA in serum by polymerase chain reaction. Scand J Infect Dis 1994; 26: 479-85.
36. Iwama A, Yoshida M, Miwa A, Obayashi T, Sakamoto S, Miura Y. Improved survival from fungaemia in patients with haematological malignancies: Analysis of risk factors for death and usefulness of early antifungal therapy. Eur J Haematol 1993; 51: 156-60.
37. Nelson R, Shibata N, Podzorski R, Herron MJ. Candida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanism of action. Clin Microbiol Rev 1991; 4: 1-19.
38. Suzuki S. Immunochemical studies on mannan, the antigenic polysaccharide of pathogenic yeasts in man of the genus Candida. Yakugaku Zasshi 1995; 115: 280-94
39. Odds FC, Evans G. Distribution of pathogenic yeasts and humoral antibodies to Candida among hospital in-patients. J Clin Pathol 1980; 33: 750-6.
40. Herent P, Stynen D, Hernando F, Fruit J, Poulain D. Retrospective evaluation of two latex agglutination tests for the detection of circulating antigen during invasive candidosis. J Clin Microbiol 1992; 30: 2158-64.
41. Kappe R, Muller J. Rapid clearance of Candida albicans mannan antigen by liver and spleen in contrast to prolonged circulation of Cryptococcus neoformans antigen. J Clin Microbiol 1991; 29: 1665-9.
42. Poulain D, Robert R, Mesnard F, Sendid B, Lepage G, Camus D. Clearances of Candida albicans derived α- and β-linked mannose residues in sera from patients with candidiasis. Eur J Clin Microbiol Infect Dis 1997; 16: 16-20.
43. Jouault T, Delaunoy C, Sendid B, Ajana F, Poulain D. Differential humoral response against α- and β-linked mannose residues associated with tissue invasion by Candida albicans. Clin Diagn Lab Immunol 1997; 4: 328-33.
44. Preisler H, Hasenclever H, Henderson E. Anti-Candida antibodies in patients with acute leukemia. A prospective study. Am J Med 1971; 51: 352-61.
45. Reiss E. ed. Molecular Immunology of Mycotic and Actinomycotic Infections. Elsevier, New York, 1986.
46. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28: 350-6.
47. Obayashi T, Tamura H, Tanaka S, Ohki M, Takahashi S, Kawai T. Endotoxin-inactivating activity in normal and pathological human blood samples. Infect Immun 1986; 53: 294-7.
48. Obayashi T, Yoshida M, Tamura H, Aketagawa J, Tanaka S, Kawai T. Deter nination of plasma (1→3)-β-D-glucan: a new diagnostic aid to deep mycosis. J Med Vet Mycol 1992; 30: 275-80.
49. Patterson TF, Miniter P, Ryan JL, Andriole VT. Effect of immunosuppression and amphotericin B on Aspergillus, anugenemia in an experimental n odel. J Infect Dis 1988; 158: 422.
50. Patterson TF, Miniter P, Dijkstra J, Szoka FC, Ryan JL, Andnole VT. Treatment of experimental invasive aspergillosis with novel amphotericin B/cholesterol-sulfate complexes. J Infect Dis 1989; 159: 717-24.
51. Walsh TF, Lee JW, Sien T, Schaufele R, Bacher J, Switchenko AC, Goodman TC, Pizzo PA. Serum D-arabinitol measured by automated enzymatic assay for detection and therapeutic monitoring of experimental disseminated candidiasis: correlation with tissue concentrations of Candida albicans. J Med Vet Mycol 1994; 32: 205-15.
52. Francis P, Lee JW, Hoffman A, Francesconi A, Bacher J, Shelhamer J, Pizzo PA, Walsh TJ. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistent granulocytopenic rabbits: the potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection. J Infect Dis 1994; 169: 356-68.
53. Wheat LJ, Connolly-Stringfield P, Blair R, Connolly K, Garringer T, Katz BP. Histoplasmosis relapse in patients with AIDS. detection with Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med 1991; 115: 936-41.
54. Wheat LJ, Connolly-Stringfield P, Blair R, Connolly K, Garringer T, Katz BP, Gupta M. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Am J Med 1992; 92: 153-60.
55. Denning DW, Tucker RM, Hostetler JS, Gill S, Stevens DA. Oral itraconazole therapy of cryptococcal meningitis and cryptococcosis in patients with AIDS. In: Bossche HV, Mackenzie DWR, Cauweribergh G, Drouhet E, Dupont B, Van Cutsem J, eds. Mycoses in AIDS Patients, Plenum Press, New York. 1990: 305-24.
56. Powderly WG, Cloud GA, Dismukes WE, Saag MS. Measurement of cryptococcal antigen in serum and cerebrospinal fluid. value in the management of AIDS-associated cryptococcal meningitis. J Infect Dis 1994; 18: 789-92.
57. Walsh TJ, Merz WG, Lee JW, Shaufele R, Wein T, Whitcomb PO, Ruddel M, Burns W, Wingard JR, Switchenko AC, Goodman T, Pizzo PA. Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol. Am J Med 1995; 99: 164-72.
58. Haynes K, Rogers TR. Value of antigen detection in predicting invasive pulmonary aspergillosis. Lancet 1990; 336: 1210-13.
59. Spreadbury C, Holden D, Aufauvre-Brown A, Bainbridge B, Cohen J. Detection of Aspergillus fumigatus by polymerase chain reaction. J Clin Microbiol 1993; 31: 615-21.
60. Tang CM, Holden DW, Aufauvre-Brown A, Cohen J. The detection of Aspergillus spp. by the polymerase chain reaction and its evaluation in bronchoalveolar lavage fluid. Am Rev Respir Dis 1993; 148: 1313-7.
61. Einsele H, Hebart H, Roller G, Lóffler J, Rothenhöfer, Müller CA, Bowden A, van Burik J, Engelhard D, Kanz L, Schumacher U. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997; 35: 1353-60.